Study to confirm the effect of continuous ingestion of foods containing Lactobacillus brevis subsp. coagulans (Labre) on intestinal regulation. - Study to confirm the effect of continuous ingestion of foods containing Lactobacillus brevis subsp. coagulans (Labre) on intestinal regulation.

Medical Corporation Hokubukai Utsukushigaoka Hospital0 个研究点目标入组 70 人开始时间: 2023年6月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjects who have a history of heart, liver, kidney disease, organ damage, diabetes, or other serious diseases (2) Subjects who have a history of gastrointestinal surgery (excluding appendectomy) (3) Subjects who are currently receiving medical drug treatment (4) Subjects who are pregnant, wish to become pregnant during the study, or are breastfeeding (5) Subjects who regularly use health functional foods, health foods, supplements, etc. that advocate intestinal regulation, and those who cannot stop using them during the study period (6) Subjects who take foods or supplements containing lactobacilli or bifidobacteria 3 times or more a week (Suguki pickle, bran pickle, kimchi, "Labre capsules", etc.) (7) Shift workers, including late-night shifts (8) Subjects who drink more than 60 g pure alcohol equivalent/day on average (9) Subjects who smoke an average of 21 cigarettes or more per day (10) Subjects who donated blood within 3 months at screening (11) Subjects who are participating in clinical research or monitoring (food, pharmaceuticals, cosmetics) other than this research, or plan to participate during this research period (12) Subjects who are judged to be inappropriate for this study with other reasons by the principal investigator.

发起方

Medical Corporation Hokubukai Utsukushigaoka Hospital